Efficacy and safety of pegylated interferon alpha-2a in patients with essential thrombocythemia (ET) and polycythemia vera (PV): results of a phase 2 study after a 7-year median follow-up

BACKGROUND: The durability of responses and long-term safety of pegylated interferon alpha-2a (PEG-IFN-a-2a) in patients with polycythemia vera and essential thrombocythemia have not been reported. Here, we present long-term efficacy and safety data from a single-center, prospective, phase 2 study,...

Descripción completa

Detalles Bibliográficos
Autores principales: Masarova, Lucia, Patel, Keyur P., Newberry, Kate J., Cortes, Jorge, Borthakur, Gautam, Konopleva, Marina, Estrov, Zeev, Kantarjian, Hagop, Verstovsek, Srdan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2017
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5421384/
https://www.ncbi.nlm.nih.gov/pubmed/28291640
http://dx.doi.org/10.1016/S2352-3026(17)30030-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5421384/
https://www.ncbi.nlm.nih.gov/pubmed/28291640
http://dx.doi.org/10.1016/S2352-3026(17)30030-3

Ejemplares similares